Amyotrophic lateral sclerosis: Part 2. Etiopathogenesis.
about
Peripherally induced oromandibular dystonia.Neuroplasticity and Repair in Rodent Neurotoxic Models of Spinal Motoneuron DiseaseEpigenetic Research of Neurodegenerative Disorders Using Patient iPSC-Based ModelsAge and founder effect of SOD1 A4V mutation causing ALSReduced expression of the Kinesin-Associated Protein 3 (KIFAP3) gene increases survival in sporadic amyotrophic lateral sclerosisAdult onset motor neuron disease: worldwide mortality, incidence and distribution since 1950.Effect of bromocriptine and metoclopramide on serum prolactin levels in patients with amyotrophic lateral sclerosis.Finding inhibitors of mutant superoxide dismutase-1 for amyotrophic lateral sclerosis therapy from traditional chinese medicine.Beyond Guam: the cyanobacteria/BMAA hypothesis of the cause of ALS and other neurodegenerative diseases.Hereditary canine spinal muscular atrophy: canine motor neuron diseasePredictive equations over-estimate the resting energy expenditure in amyotrophic lateral sclerosis patients who are dependent on invasive ventilation support.Using respiratory rate and thoracic movement to assess respiratory insufficiency in amyotrophic lateral sclerosis: a preliminary study.Intraspinal cell transplantation for targeting cervical ventral horn in amyotrophic lateral sclerosis and traumatic spinal cord injury.Fragmentation of the Golgi apparatus of motor neurons in amyotrophic lateral sclerosisImmunologic reactions in amyotrophic lateral sclerosis brain and spinal cord tissueATF3 expression improves motor function in the ALS mouse model by promoting motor neuron survival and retaining muscle innervation.New insight into neurodegeneration: the role of proteomics.Vascular mechanism of axonal degeneration in peripheral nerves in hemiplegic sides after cerebral hemorrhage: An experimental study.Carpal tunnel syndrome in amyotrophic lateral sclerosis and late onset cerebellar ataxia.Therapeutic developments in amyotrophic lateral sclerosis.Immunohistochemical characterization of the inflammatory infiltrate in amyotrophic lateral sclerosis.Neurotrophic action of autopsied ventral spinal cord extracts in patients with amyotrophic lateral sclerosis on the ventral spinal cord of rat embryo.Extracts of muscle from patients with amyotrophic lateral sclerosis enhance neurite outgrowth from ventral spinal cord explants of rat embryo.Selective and asymmetric vulnerability of corticospinal and spinocerebellar tracts in motor neuron disease.Host genetic background influences diverse neurological responses to viral infection in mice.Adeno-associated virus-mediated delivery of a recombinant single-chain antibody against misfolded superoxide dismutase for treatment of amyotrophic lateral sclerosis.Mouse inoculation studies reveal no transmissible agent in amyotrophic lateral sclerosis.Palliative care and circumstances of dying in German ALS patients using non‐invasive ventilation
P2860
Q24679760-5BB9E5CC-8BF6-4E3D-9E75-E3BD6757D941Q26767067-BDB7C680-52F3-4B8E-AB06-7F507C362880Q26772307-42DAB856-78AB-48F7-9433-52B764F2E71FQ28754373-581B5BA6-3C0E-41AE-A04F-3CC3DAF06495Q28943310-D311085B-BEB0-41A1-A21C-44CD5D691285Q33592117-DAA742C2-4DD1-4412-87F3-AD70F77241B3Q33631073-9F16DFBC-1FAF-4862-9C4A-57875299B679Q33736326-C0198ACB-B9F7-4F6B-A89A-56B1027229CBQ34020244-96B11D58-0AA3-4661-BBAC-D85827139FA4Q34081161-CBCF646E-2C47-4C33-8860-A89EA92890BAQ34128732-65AC416B-C211-43C3-99EA-F4BD15DE2844Q34523766-AE4F5839-66B0-4ED7-B125-33091453411EQ35591250-61E7C3E5-9FD0-4A10-9349-D481EBC41078Q35830648-CAE84E58-7A5B-44C3-8A69-0DE381985FACQ35830662-CC5B5F9F-1122-4128-B30F-F7D6555741A0Q37543804-137DB77C-AF0D-4366-84CD-43E342FF5F05Q38170010-63CB7138-89EB-423F-A551-92C97D79A2BEQ38623703-3452E05E-2D3D-4519-92D0-7C7513A97741Q39463271-F6353473-5918-4FE8-8E53-B30A685D7EA1Q40408954-CBECE189-4604-4150-BAF1-30A6DB486FB7Q41215835-EFE197EE-C29E-40FA-BA5E-01F5D6D2DE38Q41280772-EC85DC7B-53A4-4107-91E2-DA33DB6AC2B4Q41329942-6D6AEBA3-F8B9-47E0-AB0D-CD74355AD5BDQ41888493-8D9A7D57-8D57-46EF-BC13-43FE2061E579Q41931819-4EECB63E-308C-4B15-8A26-B2B175FEDB9EQ42003398-61764B73-D769-432E-92EC-B4A3E5D462B9Q49031026-2FEEC412-0B06-4B31-A4F8-87E9148BA7F5Q58124942-1872EB60-F8EA-4354-B512-89C3599BBC4E
P2860
Amyotrophic lateral sclerosis: Part 2. Etiopathogenesis.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Amyotrophic lateral sclerosis: Part 2. Etiopathogenesis.
@en
type
label
Amyotrophic lateral sclerosis: Part 2. Etiopathogenesis.
@en
prefLabel
Amyotrophic lateral sclerosis: Part 2. Etiopathogenesis.
@en
P2860
P356
P1433
P1476
Amyotrophic lateral sclerosis: Part 2. Etiopathogenesis.
@en
P2093
P2860
P304
P356
10.1002/ANA.410180402
P577
1985-10-01T00:00:00Z